Abstract
A sensitive and selective method for the determination of the pyridinium metabolite (HPP +) derived from the antipsychotic drug haloperidol (HP) in brain tissue, plasma and urine using high-performance liquid chromatography with fluorescence detection is described. The HPP + present in biological samples was extracted using a Sep-Pak C 18 cartridge. Recoveries of HPP + ranged from 78 to 90%. Final separation and quantitative estimations of HPP + were achieved on a C 18 reversed-phase column employing a mobile phase of acetonitrile—30 m M ammonium acetate (40:60, v/v) containing 10 m M triethylamine and adjusted to pH 3 with trifluoroacetic acid. The fluorescence detection utilized an excitation wavelength of 304 nm and an emission wavelength of 374 nm. Standard curves were linear in the range of 2.5–100 ng/ml for brain tissue homogenate and plasma samples and 10–500 ng/ml for urine samples. The detection limit of HPP + was about 1 ng/ml in all biological samples. The concentrations of HPP + in brain tissue, plasma and urine from HP-treated rats were determined using this method.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Chromatography B: Biomedical Sciences and Applications
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
